Commentary By Josh Remick, PGY-2
In the December 27th 2006 issue of JAMA, Yang et al. reported the results of a nested case-control study of United Kingdom patients entitled “Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture.” …
Commentary By Josh Remick, PGY-2
In the December 27th 2006 issue of JAMA, Yang et al. reported the results of a nested case-control study of United Kingdom patients entitled “Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture.” …
Commentary By: Minisha Sood PGY-3
The FDA has received reports of 90 patients with moderate to end-stage kidney disease who have undergone MRI or MRA with a gadolinium-based contrast agent and subsequently developed a new disease known as …
Recently, two large clinical trials in Kenya and Uganda that examined the role of circumcision in men to prevent the spread of HIV were halted on the grounds that not offering circumcision to men taking part in the trial would be …
Last week, the FDA issued a public health advisory regarding the use of methadone (trade name Dolophine) for chronic pain. Death and life threatening side effects have been reported in patients newly …
Believe it or not…Have a great weekend.
Update 12/12/06 Download new NY DOH Alert
Several Taco Bell restaurants in our area have been shut down recently due to an outbreak of E. Coli O157:H7. At least 22 people are infected, and most are under age 18. Interestingly, …
Low HDL is a well known independent risk factor for atherosclerotic disease. As a result, there have been several attempts to develop medications to raise HDL. Specific targets include the inhibition of cholesteryl ester transfer protein, which …
Welcome to the official launch of the NYU Internal Medicine Residency Program’s Blog- Clinical Correlations. We hope this site becomes a part of your daily routine. Each weekday we will be posting compelling medical content including:
1. clinical …